These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4442275)

  • 1. Recurrence of ovulation after daily, oral administration of 10 mg of norethindrone on day 15-22 and on day 8-15 of the human menstrual cycle.
    Nygren KG; Johansson ED
    Contraception; 1974 Mar; 9(3):257-64. PubMed ID: 4442275
    [No Abstract]   [Full Text] [Related]  

  • 2. The contraceptive efficacy of 10mg or 25mg of norethindrone given orally on day 15-22 of the human menstrual cycle.
    Nygren KG; Johansson ED; Wide L
    Contraception; 1974 Mar; 9(3):249-56. PubMed ID: 4442274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of norethindrone and some other synthetic gestagens upon the peripheral plasma levels of progesterone and estradiol during early, human pregnancy.
    Nygren KG; Johansson ED
    Acta Obstet Gynecol Scand; 1975; 54(1):57-63. PubMed ID: 46683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of postovulatory norethindrone and estrogens on the plasma levels of estrogen and progesterone in rhesus monkeys.
    Bosu WT; Johansson ED
    Contraception; 1974 Apr; 9(4):357-67. PubMed ID: 4216444
    [No Abstract]   [Full Text] [Related]  

  • 5. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
    Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbations of the human menstrual cycle by oxymetholone.
    Cox DW; Heinrichs WL; Paulsen AC; Conrad SH; Schiller HS; Hezl MR; Herrmann WL
    Am J Obstet Gynecol; 1975 Jan; 121(1):121-6. PubMed ID: 1115110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intranasal administration of norethisterone on folliculogenesis, cervical mucus, vaginal cytology, endometrial morphology and reproductive-endocrine profile in women.
    Kumar TC; Shah RS; Chitlange SM; Hazari KT; Gopalkrishnan K; Vadigoppula AD; Vernekar VJ; Borkar DM; Puri CP
    Contraception; 1991 Sep; 44(3):245-67. PubMed ID: 1764942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive endocrine effects of intranasal administration of norethisterone (NET) to women.
    Shah RS; Toddywalla V; Maskati BT; Desai AD; Karnik PP; David GF; Anand Kumar TC
    Contraception; 1985 Aug; 32(2):135-47. PubMed ID: 3935371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone.
    Odlind V; Weiner E; Johansson ED
    Contraception; 1979 Feb; 19(2):197-206. PubMed ID: 428235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructure of human uterine epithelium at the time of implantation after postovulatory administration of norethindrone.
    Nilsson O; Nygren KG
    Ups J Med Sci; 1974; 79(2):65-71. PubMed ID: 4837833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive endocrine effects of intranasal administration of norethisterone to adult female rhesus monkeys (Macaca mulatta).
    Puri V; David GF; Dubey AK; Puri CP; Anand Kumar TC
    J Reprod Fertil; 1986 Jan; 76(1):215-20. PubMed ID: 3944792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of progesterone and oestradiol after injections of 17 -hydroxyprogesterone caproate during the luteal phase of the normal menstrual cycle.
    Johansson ED
    Acta Obstet Gynecol Scand; 1973; 52(1):37-40. PubMed ID: 4688541
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma levels of norethindrone after i.m. injection of 200 mg norethindrone enanthate.
    Weiner E; Johansson ED
    Contraception; 1975 Apr; 11(4):419-25. PubMed ID: 1122756
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
    Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S
    Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of norethisterone oenanthate on ovarian function.
    Weiner E; Johansson ED
    Acta Endocrinol (Copenh); 1976 Oct; 83(2):386-92. PubMed ID: 989667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ethinyl estradiol administration during the follicular phase of the menstrual cycle on LH, FSH, progesterone and estradiol levels in the subsequent luteal phase.
    Dhont M; Vandekerckhove D; Vermeulen A
    J Clin Endocrinol Metab; 1974 Sep; 39(3):465-70. PubMed ID: 4416191
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
    McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
    Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of norethisterone on pituitary and ovarian function.
    Collins WP; Koullapis EN; Ferguson KM; Biswas S; Sharples MJ; Sommerville IF
    Acta Endocrinol (Copenh); 1974 Feb; 75(2):357-67. PubMed ID: 4406549
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
    Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
    Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.